Shanghai Mental Health Center: Depression trials

The registry lists 35 Depression studies with Shanghai Mental Health Center as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 7Phase 3 2Phase 4 8No phase 19(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tracking Risk in Adolescents and Children for Early Identification of Common Mental DisordersNot yet recruitingNCT07744490
• Neural Mechanisms of Temporal Interference Stimulation on Improving Social Reward Function in DepressionRecruitingNCT07287878Not applicable
• A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar DisorderRecruitingNCT07031661
• Non-invasive BCI and Application Verification for Depressed PeopleRecruitingNCT06417437Phase 4
• Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation TreatmentRecruitingNCT06385405Not applicable
• Clinical Study of Compound Ciwujia Granules in the Treatment of DepressionActive, not recruitingNCT07085143Phase 4
• Efficacy and Safety of Toluedesvenlafaxine Hydrochloride Extended-release Tablets in Somatic Symptoms of DepressionCompletedNCT05849272Phase 4
• A Trial of Enhanced Versus Standard Measurement-Based Care Implementation for DepressionStatus unknownNCT05577494
• Multi-factor Model Constraction for Early Warning and Diagnosis of MDDStatus unknownNCT05529576Phase 4
• Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) StudyStatus unknownNCT05527951Not applicable
• Efficacy and Safety of Light Therapy in the Treatment of Non-seasonal Depressive Disorder in Chinese PopulationStatus unknownNCT05499117Not applicable
• A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive DisorderStatus unknownNCT05148169Phase 4
• A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial TreatmentStatus unknownNCT05145270Phase 4
• A Study of Xiongdan Wan Treating DepressionCompletedNCT05136365Phase 2
• Establish a Specific Cohort Database for Depressive DisordersActive, not recruitingNCT05095662
• Quality of Life in Chinese Working and School Age Population With MDDStatus unknownNCT04986124
• Bear Bile Pill as add-on the Treatment of MDDStatus unknownNCT04509882Phase 2
• Reliability and Validity of FIBSER, STAR-P, HEA Scale The Reliability and Validity of Chinese Version of FIBSER, STAR-P, HEA Scale in Depression AssessmentStatus unknownNCT04500379
• Verification of the Reliability and Validity of THINC-it Tool in Bipolar DepressionCompletedNCT04471454
• Comparison of Anyu Peibo With Placebo in Treatment of MDD in ChinaStatus unknownNCT04210973Phase 3
• A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical FeaturesStatus unknownNCT04209166Not applicable
• A Kynurenine Pathway-based Molecular Imaging Study of Individualized Diagnosis and Treatment for Major Depressive DisorderStatus unknownNCT04208932
• The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive DepressionStatus unknownNCT04156425Not applicable
• Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive DisorderStatus unknownNCT03899194Not applicable
• The China Longitudinal Aging Study of Cognitive ImpairmentStatus unknownNCT03672448
• The Study of Mindfulness-based Cognitive Therapy and Major Depressive DisorderStatus unknownNCT03558256Not applicable
• Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and DepressionStatus unknownNCT03329287Not applicable
• Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological CharacteristicsStatus unknownNCT03219008Phase 4
• Comparison of Anyu Peibo With Placebo in Treatment of MDD，ⅡbCompletedNCT03183505Phase 2
• Comparison of Yuxintine With Placebo in Treatment of MDDStatus unknownNCT02395263Phase 2
• Comparison of Anyu Peibo With Placebo in Treatment of MDDCompletedNCT02380066Phase 2
• Comparison of Orcinoside With Placebo in Treatment of MDDCompletedNCT02191384Phase 2
• The Efficacy And Cognitive Impairment Of Modified Electroconvulsive TherapyCompletedNCT02066077Not applicable
• Algorithm Guided Treatment Strategies for Major Depressive DisorderStatus unknownNCT01764867Phase 4
• A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in DepressionCompletedNCT00866593Phase 2/3